Ananda Developments - Investor Meet Company Presentation
Announcement provided by
Ananda Developments Plc · ANA30/10/2024 07:30
30 October 2024
ANANDA DEVELOPMENTS PLC
("Ananda" or the "Company")
Investor Presentation via Investor Meet Company.
Ananda Developments plc (AQSE: ANA), a Company focused on the development of CBD based therapies for the treatment of a range of complex inflammatory pain conditions, is pleased to announce that following the release of the Company's Interims Results, Melissa Sturgess will provide a live update presentation via Investor Meet Company on 15 Nov 2024, 12:30 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 Nov 2024, 09:00 GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Ananda Developments Plc via:
https://www.investormeetcompany.com/ananda-developments-plc/register-investor
Investors who already follow Ananda Developments Plc on the Investor Meet Company platform will automatically be invited.
-Ends-
To stay abreast of the latest developments at Ananda, we encourage you to follow our social media channels which are:
· Investor Hub: investors.anandadevelopments.com
· Instagram: https://instagram.com/anandadevelopments?igshid=YmMyMTA2M2Y=
· LinkedIn: https://www.linkedin.com/company/anadevelopments/
· Twitter: https://twitter.com/AnandaPlc
· Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register-investor
-Ends-
The Directors of the Company accept responsibility for the contents of this announcement.
|
ANANDA DEVELOPMENTS PLC |
+44 (0)7463 686 497 |
|
|
ir@anandadevelopments.com |
|
Chief Executive Officer |
|
|
Melissa Sturgess |
|
|
|
|
|
Finance Director |
|
|
Jeremy Sturgess-Smith |
|
|
|
|
|
SP ANGEL CORPORATE FINANCE LLP |
+44 (0)20 3470 0470 |
|
|
|
|
Corporate Finance |
|
|
Richard Morrison |
|
|
|
|
|
|
|
|
Corporate Broking |
|
|
Abigail Wayne |
|
|
Rob Rees
|
|
|
Yellow Jersey PR (media enquiries) Sarah MacLeod Charles Goodwin Zara McKinlay |
+44 (0)20 3004 9512 ananda@yellowjerseypr.com |
About Ananda Developments
Ananda is an AQSE-listed life sciences company focused on the research and clinical development of CBD-based therapies for a range of complex inflammatory pain conditions.
For more information, please visit: https://anandadevelopments.com
https://investors.anandadevelopments.com/link/drLkqe
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
